These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 932502)

  • 21. Circulating interferon in man after administration of exogenous human leukocyte interferon.
    Emödi G; Just M; Hernandez R; Hirt HR
    J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Distribution of human interferon in organs and tissues after its administration to man and animals].
    Maiakova SA; Berulava II; Gavrilova IE; Kuznetsov VP
    Vopr Virusol; 1980; (5):594-6. PubMed ID: 6159738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
    Billiau A; De Somers P; Edy VG; De Clercq E; Heremans H
    Antimicrob Agents Chemother; 1979 Jul; 16(1):56-63. PubMed ID: 475375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography.
    Jankowski WJ; Davey MW; O'Malley JA; Sulkowski E; Carter WA
    J Virol; 1975 Nov; 16(5):1124-30. PubMed ID: 1185850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-appearance of injected fibroblast interferon in circulation.
    Edy VG; Billiau A; De Somer P
    Lancet; 1978 Feb; 1(8061):451-2. PubMed ID: 75485
    [No Abstract]   [Full Text] [Related]  

  • 26. No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits.
    Mogensen KE; Pyhälä L; Törmä E; Cantell K
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Jun; 82(3):305-10. PubMed ID: 4368958
    [No Abstract]   [Full Text] [Related]  

  • 27. Stable and unstable forms of human fibroblast interferon.
    Edy VG; Desmyter J; Billiau A; De Somer P
    Infect Immun; 1977 May; 16(2):445-8. PubMed ID: 863511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells.
    Smith TJ; Wagner RR
    J Exp Med; 1967 Apr; 125(4):559-77. PubMed ID: 4163879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of rhinoviruses to human leukocyte and fibroblast interferons.
    Came PE; Schafer TW; Silver GH
    J Infect Dis; 1976 Jun; 133 Suppl():A136-9. PubMed ID: 180194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gel chromatography of virus-induced interferon from exudate granulocytes].
    Hellmann W; Kohlhage H
    Arch Gesamte Virusforsch; 1973; 40(1):128-31. PubMed ID: 4692623
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon administered in the cerebrospinal space and its effect on rabies in rabbits.
    Ho M; Nash C; Morgan CW; Armstrong JA; Carroll RG; Postic B
    Infect Immun; 1974 Feb; 9(2):286-93. PubMed ID: 4816460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic modifications of human fibroblast and leukocyte interferons.
    Otto MJ; Sedmak JJ; Grossberg SE
    J Virol; 1980 Aug; 35(2):390-9. PubMed ID: 6160260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A radioimmunoassay of human leukocyte interferon using protein A-containing Staphylococcus aureus.
    Daubas P; Mogensen E
    J Immunol Methods; 1982; 48(1):1-12. PubMed ID: 6173442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial interaction of human fibroblast and leukocyte interferons with FS-4 fibroblasts.
    Gardner LJ; Vilcek J
    J Gen Virol; 1979 Jul; 44(1):161-8. PubMed ID: 227987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copper chelate affinity chromatography of human fibroblast and leucocyte interferons.
    Chadha KC; Grob PM; Mikulski AJ; Davis LR; Sulkowski E
    J Gen Virol; 1979 Jun; 43(3):701-6. PubMed ID: 479851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The functioning of the interferon system with different methods and dosages of recombinant alpha 2-interferon (reaferon) administration].
    Malinovskaia VV; Murzabaeva RT; Manakhova LS; Mironova LL
    Vopr Virusol; 1989; 34(2):180-3. PubMed ID: 2474904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The structure of human interferons.
    Rubinstein M
    Biochim Biophys Acta; 1982 Sep; 695(1):5-16. PubMed ID: 6182912
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of human interferon-beta in monkeys.
    Hilfenhaus J; Damm H; Hofstaetter T; Mauler R; Ronneberger H; Weinmann E
    J Interferon Res; 1981; 1(3):427-36. PubMed ID: 6180075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Distribution of exogenous interferon in experimental animals following intratracheal administration].
    Fedorova IuB; Nekliudova LI
    Vopr Virusol; 1975; (4):416-8. PubMed ID: 1216832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.